Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy

Background Whether echocardiographic markers of remodeling are associated with ventricular tachyarrhythmias is unknown. Objective The purpose of this study was to determine whether a transthoracic echocardiographic (TTE) marker of spherical left ventricular (LV) remodeling is associated with appropr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart rhythm 2016-02, Vol.13 (2), p.490-497
Hauptverfasser: Levine, Yehoshua C., MD, Matos, Jason, MD, Rosenberg, Michael A., MD, Manning, Warren J., MD, Josephson, Mark E., MD, Buxton, Alfred E., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Whether echocardiographic markers of remodeling are associated with ventricular tachyarrhythmias is unknown. Objective The purpose of this study was to determine whether a transthoracic echocardiographic (TTE) marker of spherical left ventricular (LV) remodeling is associated with appropriate implantable cardioverter-defibrillator (ICD) therapy in patients with primary prevention ICDs. Methods From TTE images, we calculated sphericity index (SI), the ratio of biplane LV end-diastolic volume to the volume of a hypothetical sphere with a diameter of the LV end-diastolic length, and examined the relation between SI and therapy for ventricular tachyarrhythmias in 278 patients with primary prevention ICDs and in 50 controls without structural heart disease or ventricular arrhythmias. Results SI in normal healthy adult subjects and in subjects receiving ICDs was 0.44 ± 0.02 and 0.65 ± 0.04, respectively ( P
ISSN:1547-5271
1556-3871
DOI:10.1016/j.hrthm.2015.09.022